Literature DB >> 21415359

ABO blood group and risk of colorectal cancer.

Hamed Khalili1, Brian M Wolpin, Edward S Huang, Edward L Giovannucci, Peter Kraft, Charles S Fuchs, Andrew T Chan.   

Abstract

BACKGROUND: Recent studies have shown an association between non-O blood group and risk of pancreatic cancer. It is unclear whether this association is observed with other gastrointestinal malignancies, including colorectal cancers.
METHODS: We examined the relationship between ABO blood group and the risk of incident colorectal cancer in two large prospective cohorts. We calculated HR using Cox proportional hazard modeling while adjusting for known risk factors of colorectal cancer.
RESULTS: During 996,779 person-years of follow-up, we documented 1,025 incident cases of colorectal cancers. Compared to individuals with blood group O, the multivariate-adjusted HR were 1.08 (95% CI, 0.94-1.24) for blood group A, 1.20 (95% CI, 1.00-1.45) for blood group B, and 1.08 (95% CI, 0.85-1.36) for blood group AB.
CONCLUSION: In two large prospective cohorts, we did not observe a statistically significant association between ABO blood group and risk of colorectal cancer. IMPACT: These results do not support an association between ABO blood group and risk of colorectal cancer. ©2011 AACR.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21415359      PMCID： PMC3089692          DOI： 10.1158/1055-9965.EPI-10-1250

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


  12 in total

1.  ABO blood groups, rhesus types, and colorectal adenocarcinoma. A retrospective study of 747 cases.

Authors:  T B Halvorsen
Journal:  Scand J Gastroenterol       Date:  1986-10       Impact factor: 2.423

2.  Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case-control study.

Authors:  Qiwen Ben; Kaixuan Wang; Yaozong Yuan; Zhaoshen Li
Journal:  Int J Cancer       Date:  2011-03-01       Impact factor: 7.396

3.  Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes.

Authors:  Lu Qi; Marilyn C Cornelis; Peter Kraft; Majken Jensen; Rob M van Dam; Qi Sun; Cynthia J Girman; Cathy C Laurie; Daniel B Mirel; David J Hunter; Eric Rimm; Frank B Hu
Journal:  Hum Mol Genet       Date:  2010-02-10       Impact factor: 6.150

Review 4.  Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer.

Authors:  S Hakomori
Journal:  Biochim Biophys Acta       Date:  1999-12-06

5.  ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study.

Authors:  Harvey A Risch; Herbert Yu; Lingeng Lu; Mark S Kidd
Journal:  J Natl Cancer Inst       Date:  2010-02-24       Impact factor: 13.506

6.  ABO blood group and the risk of pancreatic cancer.

Authors:  Brian M Wolpin; Andrew T Chan; Patricia Hartge; Stephen J Chanock; Peter Kraft; David J Hunter; Edward L Giovannucci; Charles S Fuchs
Journal:  J Natl Cancer Inst       Date:  2009-03-10       Impact factor: 13.506

7.  Circulating levels of inflammatory cytokines and risk of colorectal adenomas.

Authors:  Sangmi Kim; Temitope O Keku; Christopher Martin; Joseph Galanko; John T Woosley; Jane C Schroeder; Jessie A Satia; Susan Halabi; Robert S Sandler
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

8.  Clinicopathologic correlations of ABO and Rhesus blood type in colorectal cancer.

Authors:  G Slater; S Itzkowitz; S Azar; A H Aufses
Journal:  Dis Colon Rectum       Date:  1993-01       Impact factor: 4.585

9.  Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.

Authors:  Brian M Wolpin; Peter Kraft; Myron Gross; Kathy Helzlsouer; H Bas Bueno-de-Mesquita; Emily Steplowski; Rachael Z Stolzenberg-Solomon; Alan A Arslan; Eric J Jacobs; Andrea Lacroix; Gloria Petersen; Wei Zheng; Demetrius Albanes; Naomi E Allen; Laufey Amundadottir; Garnet Anderson; Marie-Christine Boutron-Ruault; Julie E Buring; Federico Canzian; Stephen J Chanock; Sandra Clipp; John Michael Gaziano; Edward L Giovannucci; Göran Hallmans; Susan E Hankinson; Robert N Hoover; David J Hunter; Amy Hutchinson; Kevin Jacobs; Charles Kooperberg; Shannon M Lynch; Julie B Mendelsohn; Dominique S Michaud; Kim Overvad; Alpa V Patel; Aleksandar Rajkovic; Maria-José Sanchéz; Xiao-Ou Shu; Nadia Slimani; Gilles Thomas; Geoffrey S Tobias; Dimitrios Trichopoulos; Paolo Vineis; Jarmo Virtamo; Jean Wactawski-Wende; Kai Yu; Anne Zeleniuch-Jacquotte; Patricia Hartge; Charles S Fuchs
Journal:  Cancer Res       Date:  2010-01-26       Impact factor: 12.701

Review 10.  Insulin and colon cancer.

Authors:  E Giovannucci
Journal:  Cancer Causes Control       Date:  1995-03       Impact factor: 2.506
View more
  21 in total

Review 1.  Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD.

Authors:  Matthew R Kudelka; Sean R Stowell; Richard D Cummings; Andrew S Neish
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-07-24       Impact factor: 46.802

Review 2.  Beyond immunohaematology: the role of the ABO blood group in human diseases.

Authors:  Giancarlo Maria Liumbruno; Massimo Franchini
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

3.  ABO blood group and risk of glioma.

Authors:  David J Cote; Mary K Downer; Emilie S Zoltick; Timothy R Smith; Meir J Stampfer
Journal:  Neuro Oncol       Date:  2017-06-01       Impact factor: 12.300

4.  ABO blood groups in relation to breast carcinoma incidence and associated prognostic factors in Moroccan women.

Authors:  S Zouine; F Marnissi; N Otmani; M Bennani Othmani; M El Wafi; K Kojok; Y Zaid; N Tahiri Jouti; N Habti
Journal:  Med Oncol       Date:  2016-05-30       Impact factor: 3.064

5.  Is there a predictive significance of ABO blood group on chemotherapy-induced thrombocytopenia in patients with stage III colon cancer?

Authors:  Ozgur Tanriverdi
Journal:  Med Oncol       Date:  2014-11-27       Impact factor: 3.064

6.  A prospective study of tea and coffee intake and risk of glioma.

Authors:  David J Cote; Alaina M Bever; Kathryn M Wilson; Timothy R Smith; Stephanie A Smith-Warner; Meir J Stampfer
Journal:  Int J Cancer       Date:  2019-07-26       Impact factor: 7.396

7.  Risk of advanced gastric precancerous lesions in Helicobacter pylori infected subjects is influenced by ABO blood group and cagA status.

Authors:  Cosmeri Rizzato; Ikuko Kato; Martyn Plummer; Nubia Muñoz; Angelika Stein; Leen Jan van Doorn; Silvia Franceschi; Federico Canzian
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

Review 8.  Hemostasis, cancer, and ABO blood group: the most recent evidence of association.

Authors:  Giancarlo Maria Liumbruno; Massimo Franchini
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

Review 9.  Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma.

Authors:  Rachael Z Stolzenberg-Solomon; Laufey T Amundadottir
Journal:  Hematol Oncol Clin North Am       Date:  2015-08       Impact factor: 3.722

10.  Statin use, hyperlipidemia, and risk of glioma.

Authors:  David J Cote; Bernard A Rosner; Stephanie A Smith-Warner; Kathleen M Egan; Meir J Stampfer
Journal:  Eur J Epidemiol       Date:  2019-09-26       Impact factor: 8.082
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.